Friday, February 18, 2022

Medication Guide - 2/18/2022

 

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More

Drug Name Active Ingredient Form;Route Appl. No. Company Date
Iclusig Ponatinib Hydrochloride TABLET;ORAL 203469 TAKEDA PHARMS USA 02/15/2022
Braftovi Encorafenib CAPSULE;ORAL 210496 ARRAY BIOPHARMA INC 02/11/2022

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment